Good Drugs, Poor Leadership - Mitarbeiter (anonym) bei BeOne: Mitarbeiterbewertung
2,0
27. Okt. 2023
Mitarbeiter (anonym)
Aktueller Mitarbeiter, mehr als 3 Jahre
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Great drugs and great co-workers
Kontras
Toxic culture, dysfunctional leadership team that is squandering the assets.
Mehr Bewertungen zu BeOne entdecken
5,0
24. Apr. 2026
Mitarbeiter (anonym)
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.
Kontras
Fast timelines and global expansion may translate into heavy workload and urgency